Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound by CNBC Markets | December 18, 2025 6:15 pm | US Markets Eli Lilly also said it has filed for Food and Drug Administration approval of the daily GLP-1 pill, called orforglipron, for obesity.
